Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Bipolar Disorder: HELP
Rodrigo Barbachan Mansur
Based on 39 articles published since 2009
(Why 39 articles?)
||||
Expertise Level
The expertise of Rodrigo Barbachan Mansur ranks in the
  • Top 0.23%
  • ... of 35,562 published authors worldwide on Bipolar Disorder
  • ... from 2009 through 2019
  • ... based on contributions to 39 articles on the topic.
Graphical view (beta)
Get your prestigious
Expert badge
similar to this:
 
Aliases Mansur, R   ·   Mansur, Rodrigo   ·   Mansur, Rodrigo Barbachan   ·   Mansur, Rodrigo B   ·   Mansur, R B
Work Locations
Details
Most likely:    University Health Network of Toronto      
2019
  • Psychiatric Clinic, Department of Neuroscience and Mental Health, University of Milan, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy. · Psychiatric Clinic, Department of Neuroscience and Mental Health, University of Milan, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy. Electronic address: · Mood Disorders Psychopharmacology Unit, Department of Psychiatry and Pharmacology, University Health Network, University of Toronto, Toronto, Canada. · Pubmed 30795487
  • Department of Psychiatry, Federal University of São Paulo, SP, Brazil. · Department of Psychiatry, University of Toronto, ON, Canada; Temerty Centre for Therapeutic Brain Intervention and Campbell Family Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada. Electronic address: · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada. · Brain and Cognition Discovery Foundation, Toronto, ON, Canada; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada. · Department of Psychiatry, Federal University of São Paulo, SP, Brazil; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada. · Pubmed 30611064
  • Department of Pharmacology, Escola Paulista de Medicina (EPM), Universidade Federal de São Paulo (UNIFESP), Rua 3 de maio 100, Ed. INFAR, 3rd floor, CEP 04044-020 São Paulo, Brazil. · Department of Psychiatry, Irmandade da Santa Casa de Misericórdia de São Paulo (ISCMSP), São Paulo, Brazil. · Mood Disorders Psychopharmacology Unit, Toronto Western Hospital, University Health Network, Toronto, ON, Canada. · Department of Psychiatry, Escola Paulista de Medicina (EPM), Universidade Federal de São Paulo (UNIFESP), Rua Pedro de Toledo, 669, 3rd floor, Vila Clementino, CEP 04039-032 São Paulo, Brazil. Electronic address: · Department of Pharmacology, Escola Paulista de Medicina (EPM), Universidade Federal de São Paulo (UNIFESP), Rua 3 de maio 100, Ed. INFAR, 3rd floor, CEP 04044-020 São Paulo, Brazil. Electronic address: · Pubmed 30321766
2018
  • Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Institute of Medical Science, University of Toronto, Toronto, ON M5S 1A8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Department of Psychiatry, University of Toronto, Toronto, ON M5T 1R8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Institute of Medical Science, University of Toronto, Toronto, ON M5S 1A8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Institute of Medical Science, University of Toronto, Toronto, ON M5S 1A8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Institute of Medical Science, University of Toronto, Toronto, ON M5S 1A8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Department of Psychiatry, Federal University of São Paulo, São Paulo 05403-903, Brazil. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Department of Psychiatry, University of Toronto, Toronto, ON M5T 1R8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Institute of Medical Science, University of Toronto, Toronto, ON M5S 1A8, Canada. · Department of Psychiatry, University of Toronto, Toronto, ON M5T 1R8, Canada. · Department of Pharmacology, University of Toronto, 399 Bathurst Street, Toronto, ON M5T 2S8, Canada. · Pubmed 29673146
  • Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada; University of Toronto, Toronto, Canada. Electronic address: · Department of Psychiatry and Behavioral Sciences, McGovern Medical School at the University of Texas Health Science Center at Houston, Houston, USA. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, USA. · Institute of Medical Biochemistry Leopoldo de Meis, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil; Centre for Neuroscience Studies, Department of Biomedical and Molecular Sciences, Queen's University, Kingston, Canada. · Center for Neuroscience in Women's Health, Stanford University, Palo Alto, USA. · Laboratory of Neuroendocrinology, The Rockefeller University, New York, USA. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada; Department of Psychiatry, Universidade Federal de São Paulo, São Paulo, Brazil; Research Group in Molecular and Behavioral Neuroscience of Bipolar Disorder, Department of Psychiatry, Universidade Federal de São Paulo, SP, Brazil. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada; University of Toronto, Toronto, Canada. · Pubmed 30391805
  • Medical University of Graz, Department of Psychiatry and Psychotherapeutic Medicine, Graz, Austria. · Medical University of Graz, Department of Psychiatry and Psychotherapeutic Medicine, Graz, Austria. Electronic address: · Research Unit on Lifestyle and Inflammation-associated Risk Biomarkers, Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University Graz, Graz, Austria. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Pubmed 29433074
  • Research Group of Molecular and Behavioral Neuroscience of Bipolar Disorder, Department of Psychiatry, Federal University of São Paulo (Unifesp), São Paulo, SP, Brazil; Post-Graduation Program in Psychiatry and Medical Psychology, Federal University of São Paulo (Unifesp), São Paulo, SP, Brazil. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network (UHN), Toronto, ON, Canada. · Developmental Cognitive Neuroscience Laboratory (DCNL), Brain Institute (InsCer), Pontifical Catholic University of Rio Grande do Sul (PUCRS), Porto Alegre, RS, Brazil. · Santa Casa School of Medical Sciences of São Paulo, São Paulo, Brazil. · Brain and Cognition Discovery Foundation (BCDF), Toronto, ON, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network (UHN), Toronto, ON, Canada; Brain and Cognition Discovery Foundation (BCDF), Toronto, ON, Canada. · Research Group of Molecular and Behavioral Neuroscience of Bipolar Disorder, Department of Psychiatry, Federal University of São Paulo (Unifesp), São Paulo, SP, Brazil; Post-Graduation Program in Psychiatry and Medical Psychology, Federal University of São Paulo (Unifesp), São Paulo, SP, Brazil; Mood Disorders Psychopharmacology Unit (MDPU), University Health Network (UHN), Toronto, ON, Canada. Electronic address: · Pubmed 29102835
  • Department of Affective Disorders, The Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou, China. · Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada. · Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada. · Department of Pharmacology, University of Toronto, Toronto, Ontario, Canada. · Department of Psychiatry and Behavioral Sciences, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX, USA. · Laboratory of Emotion and Cognition, The Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou, China. · Laboratory of Neuropsychology, University of Hong Kong, Hong Kong. · Pubmed 28944976
  • Mood Disorders Psychopharmacology Unit (MDPU), Toronto Western Hospital, University Health Network (UHN), Toronto, ON, Canada. · Grupo de Pesquisa em Neurociência Comportamental e Molecular do Transtorno Bipolar, Departamento de Psiquiatria, Universidade Federal de São Paulo (UNIFESP), São Paulo, SP, Brazil. · Brain and Cognition Discovery Foundation (BCDF), Toronto, ON, Canada. · Pubmed 30156658
2017
  • Department of Affective Disorders, the Affiliated Hospital of Guangzhou Medical University, (Guangzhou Huiai Hospital), Guangzhou Medical University, Guangzhou, China. · Department of Psychiatry, University of Toronto, Toronto, ON, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada. · Department of Psychiatry, Universidade Federal de Sao Paulo, Sao Paulo, Brazil. · Institute of Medical Science, University of Toronto, Toronto, ON, Canada. · Department of Psychiatry and Behavioral Sciences, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX, USA. · Laboratory of Emotion and Cognition, the Affiliated Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou Medical University, Guangzhou, China. · Laboratory of Neuropsychology, University of Hong Kong, Hong Kong, Hong Kong. · Pubmed 29023633
  • Institute of Medical Science, University of Toronto, Toronto, ON, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada. · Department of Psychiatry, University of Toronto, Toronto, ON, Canada. · Department of Psychiatry, Kuwait University, Kuwait City, Kuwait. · Psychosocial Oncology Clinic, University Health Network, Toronto, ON, Canada. · Department of Psychology, University of Toronto, Toronto, ON, Canada. · Neuropsychology Clinic, University Health Network, Toronto, ON, Canada. · Research Group in Molecular and Behavioral Neuroscience of Bipolar Disorder, Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil. · Department of Psychiatry, Women's College Hospital, Toronto, ON, Canada. · Department of Toxicology and Pharmacology, University of Toronto, Toronto, ON, Canada. · Pubmed 28599348
  • Department of Affective Disorders, The Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, China. · Department of Psychiatry, University of Toronto, Toronto, ON, Canada. · Institute of Medical Science, University of Toronto, Toronto, ON, Canada. · Department of Pharmacology, University of Toronto, Ontario, ON, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada. · Laboratory of Emotion and Cognition, the Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, China. · Laboratory of Neuropsychology, University of Hong Kong, Hong Kong. · Pubmed 28493605
  • Department of Psychiatry and Psychotherapy, Medical University of Graz, Graz, Austria. · Department of Psychiatry and Psychotherapy, Medical University of Graz, Graz, Austria. Electronic address: · Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Graz, Graz, Austria. · Division of Biological Chemistry, Biocenter, Medical University of Innsbruck, Innsbruck, Austria. · Institute of Laboratory Medicine, Medical Center of Munich University (LMU), Munich, Germany. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Pubmed 28482311
  • Reserach Group in Behavioral and Molecular Neuroscience of Bipolar Disorder, Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Department of Psychiatry, Clinic for Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany. · Vila Maria Outpatient Clinic, São Paulo, Brazil. · Department of Psychiatry, Irmandade da Santa Casa de Misericórdia de São Paulo (ISCMSP), São Paulo, Brazil. · Pubmed 28457001
  • Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada; Research Group in Molecular and Behavioral Neuroscience of Bipolar Disorder, Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil. Electronic address: · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Division of Endocrinology, Mount Sinai Hospital, University of Toronto, Toronto, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada; Paik Institute for Clinical Research, Inje University, Busan, Republic of Korea. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada; Department of Psychiatry, Samsung Seoul Hospital, Sungkyunkwan University, School of Medicine, Seoul, Republic of Korea. · Research Group in Molecular and Behavioral Neuroscience of Bipolar Disorder, Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil. · Medical University of Graz, Department of Psychiatry, Graz, Austria. · Research Division, Institute of Mental Health, Singapore. · Psychiatric Center Copenhagen, University of Copenhagen, Copenhagen, Denmark. · Department of Psychiatry, Stanford University, Palo Alto, CA, United States. · Department of Psychiatry, Dalhousie University, Halifax, Canada. · Pubmed 27721184
2016
  • 1Mood Disorders Psychopharmacology Unit,University Health Network,Toronto,Ontario,Canada. · Pubmed 28044944
  • Research Group in Behavioral Neuroscience of Bipolar Disorder (GP-TB), Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Department of Psychiatry, Clinic for Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany. · Vila Maria Outpatient Clinic, São Paulo, Brazil. · Department of Psychiatry, Irmandade da Santa Casa de Misericórdia de São Paulo (ISCMSP), São Paulo, Brazil. · Pubmed 27488494
  • Faculty of Kinesiology and Physical Education, University of Toronto, 55 Harbord Street, Toronto, ON, M5S2W6, Canada. · School of Kinesiology, University of British Columbia, 2146 Health Sciences Mall, Room 4606, Vancouver, BC, V6T 1Z3, Canada. · Mood Disorders Psychopharmacology Unit, Toronto Western Hospital, University Health Network, 399 Bathurst Street, MP 9-325, Toronto, ON, M5T 2S8, Canada. · Schizophrenia Program Centre for Addiction and Mental Health, 250 College Street, Toronto, ON, M5T 1R8, Canada. · School of Kinesiology, University of British Columbia, 2146 Health Sciences Mall, Room 4606, Vancouver, BC, V6T 1Z3, Canada. · Pubmed 27405745
  • Department of Psychiatry, Research Group in Behavioral Neuroscience of Bipolar Disorder (GP-TB), Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Department of Psychiatry, Clinic for Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany. · Vila Maria Outpatient Clinic, São Paulo, Brazil. · Department of Psychiatry, Irmandade da Santa Casa de Misericórdia de São Paulo (ISCMSP), São Paulo, Brazil. · Psychiatric Center Copenhagen, University of Copenhagen, Copenhagen, Denmark. · Bipolar Disorder Program and Laboratory of Molecular Psychiatry, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil. · Pubmed 27324989
  • Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil; Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. Electronic address: · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil; Department of Psychiatry, Clinic for Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany. · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil. · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil; Vila Maria Outpatient Clinic, São Paulo, Brazil. · Department of Psychiatry, Irmandade da Santa Casa de Misericórdia de São Paulo (ISCMSP), Brazil. · Medical University of Graz, Department of Psychiatry, Graz, Austria. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Pubmed 27281261
  • Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil; Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. Electronic address: · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil; Department of Psychiatry, Clinic for Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany. · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil. · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil; Vila Maria Outpatient Clinic in São Paulo, Brazil. · Department of Psychiatry, Irmandade da Santa Casa de Misericórdia de São Paulo (ISCMSP), Brazil. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Pubmed 26866976
  • Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada. · Cleveland Clinic, Cleveland, OH, USA. · Turn2Health Solutions, Willoughby, OH, USA. · Translational Psychiatry Research Group and Department of Clinical Medicine, Faculty of Medicine, Federal University of Ceara, Fortaleza, Brazil. · Department of Neuropsychiatry, University of South Carolina School of Medicine, USA. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada; Department of Pharmacology, University of Toronto, Toronto, ON, Canada. Electronic address: · Pubmed 26508286
2015
  • Mood Disorder Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada. · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Federal University of Sao Paulo, Sao Paulo, Brazil; Program of Recognition and Intervention in Individuals in AT-Risk Mental States (PRISMA), Department of Psychiatry, Universidade FeInterdisciplinary Laboratory of Clinical Neurosciences (LINC), Federal University of Sao Pauloderal de São Paulo, São Paulo, Brazil. · Mood Disorder Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Federal University of Sao Paulo, Sao Paulo, Brazil; Program of Recognition and Intervention in Individuals in AT-Risk Mental States (PRISMA), Department of Psychiatry, Universidade FeInterdisciplinary Laboratory of Clinical Neurosciences (LINC), Federal University of Sao Pauloderal de São Paulo, São Paulo, Brazil. · Mood Disorder Psychopharmacology Unit, University Health Network, Toronto, ON, Canada. · Mood Disorder Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada. Electronic address: · Pubmed 26363613
  • Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Department of Pharmacology, University of Toronto, Toronto, ON, Canada; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada. Electronic address: · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada. · Cleveland Clinic, Cleveland, OH, USA. · Medco Health Solutions, Inc, Fort Worth, TX, USA. · Translational Psychiatry Research Group and Department of Clinical Medicine, Faculty of Medicine, Federal University of Ceara, Fortaleza, Brazil. · Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada. · Pubmed 25451425
2014
  • Program for Recognition and Intervention in Individuals in At-Risk Mental States (PRISMA), Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil; Interdisciplinary Laboratory of Clinical Neuroscience (LINC), Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil. · Program for Recognition and Intervention in Individuals in At-Risk Mental States (PRISMA), Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil; Interdisciplinary Laboratory of Clinical Neuroscience (LINC), Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada. · Sunnybrook Research Institute, University of Toronto, Toronto, Ontario, Canada. · Interdisciplinary Laboratory of Clinical Neuroscience (LINC), Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil; Department of Morphology and Genetics, Federal University of São Paulo, São Paulo, Brazil. · Institute of Biomedical Research and Faculty of Biosciences, Pontifical Catholic University of Rio Grande do Sul, Porto Alegre, Brazil. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada; Sunnybrook Research Institute, University of Toronto, Toronto, Ontario, Canada. · Program for Recognition and Intervention in Individuals in At-Risk Mental States (PRISMA), Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil; Interdisciplinary Laboratory of Clinical Neuroscience (LINC), Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil. Electronic address: · Pubmed 24548785
2013
  • 1 Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada. · 3 Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada. · Pubmed 24237641
2016
  • Mood Disorders Psychopharmacology Unit, University Health Network, Department of Psychiatry and Pharmacology, University of Toronto, Toronto, Canada. · Department of Psychiatry, Western University, London and Windsor, ON, Canada. · IMPACT Strategic Research Centre, School of Medicine, Deakin University, Geelong, Vic., Australia. · Department of Psychiatry, The Florey Institute of Neuroscience and Mental Health, and Orygen, The National Centre of Excellence in Youth Mental Health, Centre for Youth Mental Health, University of Melbourne, Parkville, Vic., Australia. · Psychiatric Center Copenhagen, Faculty of Health and Medical Sciences and Department O, University of Copenhagen, Copenhagen, Denmark. · Discipline of Psychiatry, University of Adelaide, Adelaide, SA, Australia. · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Federal University of Sao Paulo, São Paulo, Brazil. · Program of Recognition and Intervention in Individuals in AT-Risk Mental States (PRISMA), Department of Psychiatry, Universidade Federal de São Paulo, São Paulo, Brazil. · Departments of Psychiatry, Pharmacology, and Psychological Clinical Science, Centre for Youth Bipolar Disorder, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada. · Pubmed 26990051
  • Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Federal University of São Paulo (UNIFESP), São Paulo, Brazil; Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. Electronic address: · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Federal University of São Paulo (UNIFESP), São Paulo, Brazil; Department of Psychiatry, Clinic for Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany. · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Federal University of São Paulo (UNIFESP), São Paulo, Brazil. · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Federal University of São Paulo (UNIFESP), São Paulo, Brazil; Vila Maria Outpatient Clinic in São Paulo, Brazil. · Department of Psychiatry, Irmandade da Santa Casa de Misericórdia de São Paulo (ISCMSP), Brazil. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Pubmed 26748249
2014
  • Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Department of Pharmacology, University of Toronto, Toronto, ON, Canada; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada. · Pubmed 24330342
Probable:    University of Toronto   Contact    
2019
  • Psychiatric Clinic, Department of Neuroscience and Mental Health, University of Milan, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy. · Psychiatric Clinic, Department of Neuroscience and Mental Health, University of Milan, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy. Electronic address: · Mood Disorders Psychopharmacology Unit, Department of Psychiatry and Pharmacology, University Health Network, University of Toronto, Toronto, Canada. · Pubmed 30795487
  • Department of Pharmacology, Escola Paulista de Medicina (EPM), Universidade Federal de São Paulo (UNIFESP), Rua 3 de maio 100, Ed. INFAR, 3rd floor, CEP 04044-020 São Paulo, Brazil. · Department of Psychiatry, Irmandade da Santa Casa de Misericórdia de São Paulo (ISCMSP), São Paulo, Brazil. · Mood Disorders Psychopharmacology Unit, Toronto Western Hospital, University Health Network, Toronto, ON, Canada. · Department of Psychiatry, Escola Paulista de Medicina (EPM), Universidade Federal de São Paulo (UNIFESP), Rua Pedro de Toledo, 669, 3rd floor, Vila Clementino, CEP 04039-032 São Paulo, Brazil. Electronic address: · Department of Pharmacology, Escola Paulista de Medicina (EPM), Universidade Federal de São Paulo (UNIFESP), Rua 3 de maio 100, Ed. INFAR, 3rd floor, CEP 04044-020 São Paulo, Brazil. Electronic address: · Pubmed 30321766
2018
  • Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Institute of Medical Science, University of Toronto, Toronto, ON M5S 1A8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Department of Psychiatry, University of Toronto, Toronto, ON M5T 1R8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Institute of Medical Science, University of Toronto, Toronto, ON M5S 1A8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Institute of Medical Science, University of Toronto, Toronto, ON M5S 1A8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Institute of Medical Science, University of Toronto, Toronto, ON M5S 1A8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Department of Psychiatry, Federal University of São Paulo, São Paulo 05403-903, Brazil. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Department of Psychiatry, University of Toronto, Toronto, ON M5T 1R8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Institute of Medical Science, University of Toronto, Toronto, ON M5S 1A8, Canada. · Department of Psychiatry, University of Toronto, Toronto, ON M5T 1R8, Canada. · Department of Pharmacology, University of Toronto, 399 Bathurst Street, Toronto, ON M5T 2S8, Canada. · Pubmed 29673146
  • Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada; University of Toronto, Toronto, Canada. Electronic address: · Department of Psychiatry and Behavioral Sciences, McGovern Medical School at the University of Texas Health Science Center at Houston, Houston, USA. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, USA. · Institute of Medical Biochemistry Leopoldo de Meis, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil; Centre for Neuroscience Studies, Department of Biomedical and Molecular Sciences, Queen's University, Kingston, Canada. · Center for Neuroscience in Women's Health, Stanford University, Palo Alto, USA. · Laboratory of Neuroendocrinology, The Rockefeller University, New York, USA. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada; Department of Psychiatry, Universidade Federal de São Paulo, São Paulo, Brazil; Research Group in Molecular and Behavioral Neuroscience of Bipolar Disorder, Department of Psychiatry, Universidade Federal de São Paulo, SP, Brazil. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada; University of Toronto, Toronto, Canada. · Pubmed 30391805
  • Medical University of Graz, Department of Psychiatry and Psychotherapeutic Medicine, Graz, Austria. · Medical University of Graz, Department of Psychiatry and Psychotherapeutic Medicine, Graz, Austria. Electronic address: · Research Unit on Lifestyle and Inflammation-associated Risk Biomarkers, Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University Graz, Graz, Austria. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Pubmed 29433074
  • Department of Affective Disorders, The Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou, China. · Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada. · Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada. · Department of Pharmacology, University of Toronto, Toronto, Ontario, Canada. · Department of Psychiatry and Behavioral Sciences, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX, USA. · Laboratory of Emotion and Cognition, The Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou, China. · Laboratory of Neuropsychology, University of Hong Kong, Hong Kong. · Pubmed 28944976
  • Mood Disorders Psychopharmacology Unit (MDPU), Toronto Western Hospital, University Health Network (UHN), Toronto, ON, Canada. · Grupo de Pesquisa em Neurociência Comportamental e Molecular do Transtorno Bipolar, Departamento de Psiquiatria, Universidade Federal de São Paulo (UNIFESP), São Paulo, SP, Brazil. · Brain and Cognition Discovery Foundation (BCDF), Toronto, ON, Canada. · Pubmed 30156658
2017
  • Department of Affective Disorders, the Affiliated Hospital of Guangzhou Medical University, (Guangzhou Huiai Hospital), Guangzhou Medical University, Guangzhou, China. · Department of Psychiatry, University of Toronto, Toronto, ON, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada. · Department of Psychiatry, Universidade Federal de Sao Paulo, Sao Paulo, Brazil. · Institute of Medical Science, University of Toronto, Toronto, ON, Canada. · Department of Psychiatry and Behavioral Sciences, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX, USA. · Laboratory of Emotion and Cognition, the Affiliated Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou Medical University, Guangzhou, China. · Laboratory of Neuropsychology, University of Hong Kong, Hong Kong, Hong Kong. · Pubmed 29023633
  • Department of Affective Disorders, The Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, China. · Department of Psychiatry, University of Toronto, Toronto, ON, Canada. · Institute of Medical Science, University of Toronto, Toronto, ON, Canada. · Department of Pharmacology, University of Toronto, Ontario, ON, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada. · Laboratory of Emotion and Cognition, the Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, China. · Laboratory of Neuropsychology, University of Hong Kong, Hong Kong. · Pubmed 28493605
  • Department of Psychiatry and Psychotherapy, Medical University of Graz, Graz, Austria. · Department of Psychiatry and Psychotherapy, Medical University of Graz, Graz, Austria. Electronic address: · Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Graz, Graz, Austria. · Division of Biological Chemistry, Biocenter, Medical University of Innsbruck, Innsbruck, Austria. · Institute of Laboratory Medicine, Medical Center of Munich University (LMU), Munich, Germany. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Pubmed 28482311
  • Reserach Group in Behavioral and Molecular Neuroscience of Bipolar Disorder, Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Department of Psychiatry, Clinic for Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany. · Vila Maria Outpatient Clinic, São Paulo, Brazil. · Department of Psychiatry, Irmandade da Santa Casa de Misericórdia de São Paulo (ISCMSP), São Paulo, Brazil. · Pubmed 28457001
  • Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada; Research Group in Molecular and Behavioral Neuroscience of Bipolar Disorder, Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil. Electronic address: · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Division of Endocrinology, Mount Sinai Hospital, University of Toronto, Toronto, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada; Paik Institute for Clinical Research, Inje University, Busan, Republic of Korea. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada; Department of Psychiatry, Samsung Seoul Hospital, Sungkyunkwan University, School of Medicine, Seoul, Republic of Korea. · Research Group in Molecular and Behavioral Neuroscience of Bipolar Disorder, Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil. · Medical University of Graz, Department of Psychiatry, Graz, Austria. · Research Division, Institute of Mental Health, Singapore. · Psychiatric Center Copenhagen, University of Copenhagen, Copenhagen, Denmark. · Department of Psychiatry, Stanford University, Palo Alto, CA, United States. · Department of Psychiatry, Dalhousie University, Halifax, Canada. · Pubmed 27721184
2016
  • Research Group in Behavioral Neuroscience of Bipolar Disorder (GP-TB), Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Department of Psychiatry, Clinic for Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany. · Vila Maria Outpatient Clinic, São Paulo, Brazil. · Department of Psychiatry, Irmandade da Santa Casa de Misericórdia de São Paulo (ISCMSP), São Paulo, Brazil. · Pubmed 27488494
  • Faculty of Kinesiology and Physical Education, University of Toronto, 55 Harbord Street, Toronto, ON, M5S2W6, Canada. · School of Kinesiology, University of British Columbia, 2146 Health Sciences Mall, Room 4606, Vancouver, BC, V6T 1Z3, Canada. · Mood Disorders Psychopharmacology Unit, Toronto Western Hospital, University Health Network, 399 Bathurst Street, MP 9-325, Toronto, ON, M5T 2S8, Canada. · Schizophrenia Program Centre for Addiction and Mental Health, 250 College Street, Toronto, ON, M5T 1R8, Canada. · School of Kinesiology, University of British Columbia, 2146 Health Sciences Mall, Room 4606, Vancouver, BC, V6T 1Z3, Canada. · Pubmed 27405745
  • Department of Psychiatry, Research Group in Behavioral Neuroscience of Bipolar Disorder (GP-TB), Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Department of Psychiatry, Clinic for Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany. · Vila Maria Outpatient Clinic, São Paulo, Brazil. · Department of Psychiatry, Irmandade da Santa Casa de Misericórdia de São Paulo (ISCMSP), São Paulo, Brazil. · Psychiatric Center Copenhagen, University of Copenhagen, Copenhagen, Denmark. · Bipolar Disorder Program and Laboratory of Molecular Psychiatry, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil. · Pubmed 27324989
  • Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil; Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. Electronic address: · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil; Department of Psychiatry, Clinic for Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany. · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil. · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil; Vila Maria Outpatient Clinic, São Paulo, Brazil. · Department of Psychiatry, Irmandade da Santa Casa de Misericórdia de São Paulo (ISCMSP), Brazil. · Medical University of Graz, Department of Psychiatry, Graz, Austria. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Pubmed 27281261
  • Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil; Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. Electronic address: · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil; Department of Psychiatry, Clinic for Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany. · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil. · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil; Vila Maria Outpatient Clinic in São Paulo, Brazil. · Department of Psychiatry, Irmandade da Santa Casa de Misericórdia de São Paulo (ISCMSP), Brazil. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Pubmed 26866976
2016
  • Mood Disorders Psychopharmacology Unit, University Health Network, Department of Psychiatry and Pharmacology, University of Toronto, Toronto, Canada. · Department of Psychiatry, Western University, London and Windsor, ON, Canada. · IMPACT Strategic Research Centre, School of Medicine, Deakin University, Geelong, Vic., Australia. · Department of Psychiatry, The Florey Institute of Neuroscience and Mental Health, and Orygen, The National Centre of Excellence in Youth Mental Health, Centre for Youth Mental Health, University of Melbourne, Parkville, Vic., Australia. · Psychiatric Center Copenhagen, Faculty of Health and Medical Sciences and Department O, University of Copenhagen, Copenhagen, Denmark. · Discipline of Psychiatry, University of Adelaide, Adelaide, SA, Australia. · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Federal University of Sao Paulo, São Paulo, Brazil. · Program of Recognition and Intervention in Individuals in AT-Risk Mental States (PRISMA), Department of Psychiatry, Universidade Federal de São Paulo, São Paulo, Brazil. · Departments of Psychiatry, Pharmacology, and Psychological Clinical Science, Centre for Youth Bipolar Disorder, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada. · Pubmed 26990051
  • Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Federal University of São Paulo (UNIFESP), São Paulo, Brazil; Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. Electronic address: · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Federal University of São Paulo (UNIFESP), São Paulo, Brazil; Department of Psychiatry, Clinic for Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany. · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Federal University of São Paulo (UNIFESP), São Paulo, Brazil. · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Federal University of São Paulo (UNIFESP), São Paulo, Brazil; Vila Maria Outpatient Clinic in São Paulo, Brazil. · Department of Psychiatry, Irmandade da Santa Casa de Misericórdia de São Paulo (ISCMSP), Brazil. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Pubmed 26748249
2014
  • Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Department of Pharmacology, University of Toronto, Toronto, ON, Canada; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada. · Pubmed 24330342
2013
  • Department of Human Biology, University of Toronto, Toronto, ON, Canada. · Pubmed 24194362
Probable:    Guangzhou Medical University      
2018
  • Department of Affective Disorders, The Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou, China. · Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada. · Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada. · Department of Pharmacology, University of Toronto, Toronto, Ontario, Canada. · Department of Psychiatry and Behavioral Sciences, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX, USA. · Laboratory of Emotion and Cognition, The Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou, China. · Laboratory of Neuropsychology, University of Hong Kong, Hong Kong. · Pubmed 28944976
2017
  • Department of Affective Disorders, the Affiliated Hospital of Guangzhou Medical University, (Guangzhou Huiai Hospital), Guangzhou Medical University, Guangzhou, China. · Department of Psychiatry, University of Toronto, Toronto, ON, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada. · Department of Psychiatry, Universidade Federal de Sao Paulo, Sao Paulo, Brazil. · Institute of Medical Science, University of Toronto, Toronto, ON, Canada. · Department of Psychiatry and Behavioral Sciences, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX, USA. · Laboratory of Emotion and Cognition, the Affiliated Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou Medical University, Guangzhou, China. · Laboratory of Neuropsychology, University of Hong Kong, Hong Kong, Hong Kong. · Pubmed 29023633
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 39 total) written by Rodrigo Barbachan Mansur about Bipolar Disorder:

  • Possible association between social cognition and metabolic dysfunctions in Bipolar Disorder and Schizophrenia: Preliminary results. 2019
  • Hypersomnia and Bipolar Disorder: A systematic review and meta-analysis of proportion. 2019
  • Oligopeptidases activity in bipolar disorder: Ndel1 and angiotensin I converting enzyme. 2019
  • Predictors of Response to Ketamine in Treatment Resistant Major Depressive Disorder and Bipolar Disorder. 2018
  • Expression of dopamine signaling genes in the post-mortem brain of individuals with mental illnesses is moderated by body mass index and mediated by insulin signaling genes. 2018
  • The relationship between inflammatory state and quantity of affective episodes in bipolar disorder. 2018
  • The differential association between history of childhood sexual abuse and body mass index in early and late stages of bipolar disorder. 2018
  • Obesity and frontal-striatal brain structures in offspring of individuals with bipolar disorder: Results from the global mood and brain science initiative. 2018
  • Coronary calcium score as an expression of multisystemic progression of bipolar disorder. 2018
  • Microbiota abnormalities and the therapeutic potential of probiotics in the treatment of mood disorders. 2017
Show List of Full Article Records
Google Searches

Learn more about Rodrigo Barbachan Mansur using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
University Health Network of Toronto
University of Toronto
Guangzhou Medical University
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
University Health Network of Toronto
2019
  • Psychiatric Clinic, Department of Neuroscience and Mental Health, University of Milan, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy. · Psychiatric Clinic, Department of Neuroscience and Mental Health, University of Milan, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy. Electronic address: · Mood Disorders Psychopharmacology Unit, Department of Psychiatry and Pharmacology, University Health Network, University of Toronto, Toronto, Canada. · Pubmed 30795487
  • Department of Psychiatry, Federal University of São Paulo, SP, Brazil. · Department of Psychiatry, University of Toronto, ON, Canada; Temerty Centre for Therapeutic Brain Intervention and Campbell Family Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada. Electronic address: · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada. · Brain and Cognition Discovery Foundation, Toronto, ON, Canada; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada. · Department of Psychiatry, Federal University of São Paulo, SP, Brazil; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada. · Pubmed 30611064
  • Department of Pharmacology, Escola Paulista de Medicina (EPM), Universidade Federal de São Paulo (UNIFESP), Rua 3 de maio 100, Ed. INFAR, 3rd floor, CEP 04044-020 São Paulo, Brazil. · Department of Psychiatry, Irmandade da Santa Casa de Misericórdia de São Paulo (ISCMSP), São Paulo, Brazil. · Mood Disorders Psychopharmacology Unit, Toronto Western Hospital, University Health Network, Toronto, ON, Canada. · Department of Psychiatry, Escola Paulista de Medicina (EPM), Universidade Federal de São Paulo (UNIFESP), Rua Pedro de Toledo, 669, 3rd floor, Vila Clementino, CEP 04039-032 São Paulo, Brazil. Electronic address: · Department of Pharmacology, Escola Paulista de Medicina (EPM), Universidade Federal de São Paulo (UNIFESP), Rua 3 de maio 100, Ed. INFAR, 3rd floor, CEP 04044-020 São Paulo, Brazil. Electronic address: · Pubmed 30321766
2018
  • Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Institute of Medical Science, University of Toronto, Toronto, ON M5S 1A8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Department of Psychiatry, University of Toronto, Toronto, ON M5T 1R8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Institute of Medical Science, University of Toronto, Toronto, ON M5S 1A8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Institute of Medical Science, University of Toronto, Toronto, ON M5S 1A8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Institute of Medical Science, University of Toronto, Toronto, ON M5S 1A8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Department of Psychiatry, Federal University of São Paulo, São Paulo 05403-903, Brazil. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Department of Psychiatry, University of Toronto, Toronto, ON M5T 1R8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Institute of Medical Science, University of Toronto, Toronto, ON M5S 1A8, Canada. · Department of Psychiatry, University of Toronto, Toronto, ON M5T 1R8, Canada. · Department of Pharmacology, University of Toronto, 399 Bathurst Street, Toronto, ON M5T 2S8, Canada. · Pubmed 29673146
  • Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada; University of Toronto, Toronto, Canada. Electronic address: · Department of Psychiatry and Behavioral Sciences, McGovern Medical School at the University of Texas Health Science Center at Houston, Houston, USA. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, USA. · Institute of Medical Biochemistry Leopoldo de Meis, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil; Centre for Neuroscience Studies, Department of Biomedical and Molecular Sciences, Queen's University, Kingston, Canada. · Center for Neuroscience in Women's Health, Stanford University, Palo Alto, USA. · Laboratory of Neuroendocrinology, The Rockefeller University, New York, USA. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada; Department of Psychiatry, Universidade Federal de São Paulo, São Paulo, Brazil; Research Group in Molecular and Behavioral Neuroscience of Bipolar Disorder, Department of Psychiatry, Universidade Federal de São Paulo, SP, Brazil. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada; University of Toronto, Toronto, Canada. · Pubmed 30391805
  • Medical University of Graz, Department of Psychiatry and Psychotherapeutic Medicine, Graz, Austria. · Medical University of Graz, Department of Psychiatry and Psychotherapeutic Medicine, Graz, Austria. Electronic address: · Research Unit on Lifestyle and Inflammation-associated Risk Biomarkers, Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University Graz, Graz, Austria. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Pubmed 29433074
  • Research Group of Molecular and Behavioral Neuroscience of Bipolar Disorder, Department of Psychiatry, Federal University of São Paulo (Unifesp), São Paulo, SP, Brazil; Post-Graduation Program in Psychiatry and Medical Psychology, Federal University of São Paulo (Unifesp), São Paulo, SP, Brazil. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network (UHN), Toronto, ON, Canada. · Developmental Cognitive Neuroscience Laboratory (DCNL), Brain Institute (InsCer), Pontifical Catholic University of Rio Grande do Sul (PUCRS), Porto Alegre, RS, Brazil. · Santa Casa School of Medical Sciences of São Paulo, São Paulo, Brazil. · Brain and Cognition Discovery Foundation (BCDF), Toronto, ON, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network (UHN), Toronto, ON, Canada; Brain and Cognition Discovery Foundation (BCDF), Toronto, ON, Canada. · Research Group of Molecular and Behavioral Neuroscience of Bipolar Disorder, Department of Psychiatry, Federal University of São Paulo (Unifesp), São Paulo, SP, Brazil; Post-Graduation Program in Psychiatry and Medical Psychology, Federal University of São Paulo (Unifesp), São Paulo, SP, Brazil; Mood Disorders Psychopharmacology Unit (MDPU), University Health Network (UHN), Toronto, ON, Canada. Electronic address: · Pubmed 29102835
  • Department of Affective Disorders, The Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou, China. · Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada. · Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada. · Department of Pharmacology, University of Toronto, Toronto, Ontario, Canada. · Department of Psychiatry and Behavioral Sciences, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX, USA. · Laboratory of Emotion and Cognition, The Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou, China. · Laboratory of Neuropsychology, University of Hong Kong, Hong Kong. · Pubmed 28944976
  • Mood Disorders Psychopharmacology Unit (MDPU), Toronto Western Hospital, University Health Network (UHN), Toronto, ON, Canada. · Grupo de Pesquisa em Neurociência Comportamental e Molecular do Transtorno Bipolar, Departamento de Psiquiatria, Universidade Federal de São Paulo (UNIFESP), São Paulo, SP, Brazil. · Brain and Cognition Discovery Foundation (BCDF), Toronto, ON, Canada. · Pubmed 30156658
2017
  • Department of Affective Disorders, the Affiliated Hospital of Guangzhou Medical University, (Guangzhou Huiai Hospital), Guangzhou Medical University, Guangzhou, China. · Department of Psychiatry, University of Toronto, Toronto, ON, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada. · Department of Psychiatry, Universidade Federal de Sao Paulo, Sao Paulo, Brazil. · Institute of Medical Science, University of Toronto, Toronto, ON, Canada. · Department of Psychiatry and Behavioral Sciences, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX, USA. · Laboratory of Emotion and Cognition, the Affiliated Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou Medical University, Guangzhou, China. · Laboratory of Neuropsychology, University of Hong Kong, Hong Kong, Hong Kong. · Pubmed 29023633
  • Institute of Medical Science, University of Toronto, Toronto, ON, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada. · Department of Psychiatry, University of Toronto, Toronto, ON, Canada. · Department of Psychiatry, Kuwait University, Kuwait City, Kuwait. · Psychosocial Oncology Clinic, University Health Network, Toronto, ON, Canada. · Department of Psychology, University of Toronto, Toronto, ON, Canada. · Neuropsychology Clinic, University Health Network, Toronto, ON, Canada. · Research Group in Molecular and Behavioral Neuroscience of Bipolar Disorder, Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil. · Department of Psychiatry, Women's College Hospital, Toronto, ON, Canada. · Department of Toxicology and Pharmacology, University of Toronto, Toronto, ON, Canada. · Pubmed 28599348
  • Department of Affective Disorders, The Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, China. · Department of Psychiatry, University of Toronto, Toronto, ON, Canada. · Institute of Medical Science, University of Toronto, Toronto, ON, Canada. · Department of Pharmacology, University of Toronto, Ontario, ON, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada. · Laboratory of Emotion and Cognition, the Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, China. · Laboratory of Neuropsychology, University of Hong Kong, Hong Kong. · Pubmed 28493605
  • Department of Psychiatry and Psychotherapy, Medical University of Graz, Graz, Austria. · Department of Psychiatry and Psychotherapy, Medical University of Graz, Graz, Austria. Electronic address: · Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Graz, Graz, Austria. · Division of Biological Chemistry, Biocenter, Medical University of Innsbruck, Innsbruck, Austria. · Institute of Laboratory Medicine, Medical Center of Munich University (LMU), Munich, Germany. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Pubmed 28482311
  • Reserach Group in Behavioral and Molecular Neuroscience of Bipolar Disorder, Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Department of Psychiatry, Clinic for Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany. · Vila Maria Outpatient Clinic, São Paulo, Brazil. · Department of Psychiatry, Irmandade da Santa Casa de Misericórdia de São Paulo (ISCMSP), São Paulo, Brazil. · Pubmed 28457001
  • Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada; Research Group in Molecular and Behavioral Neuroscience of Bipolar Disorder, Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil. Electronic address: · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Division of Endocrinology, Mount Sinai Hospital, University of Toronto, Toronto, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada; Paik Institute for Clinical Research, Inje University, Busan, Republic of Korea. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada; Department of Psychiatry, Samsung Seoul Hospital, Sungkyunkwan University, School of Medicine, Seoul, Republic of Korea. · Research Group in Molecular and Behavioral Neuroscience of Bipolar Disorder, Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil. · Medical University of Graz, Department of Psychiatry, Graz, Austria. · Research Division, Institute of Mental Health, Singapore. · Psychiatric Center Copenhagen, University of Copenhagen, Copenhagen, Denmark. · Department of Psychiatry, Stanford University, Palo Alto, CA, United States. · Department of Psychiatry, Dalhousie University, Halifax, Canada. · Pubmed 27721184
2016
  • 1Mood Disorders Psychopharmacology Unit,University Health Network,Toronto,Ontario,Canada. · Pubmed 28044944
  • Research Group in Behavioral Neuroscience of Bipolar Disorder (GP-TB), Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Department of Psychiatry, Clinic for Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany. · Vila Maria Outpatient Clinic, São Paulo, Brazil. · Department of Psychiatry, Irmandade da Santa Casa de Misericórdia de São Paulo (ISCMSP), São Paulo, Brazil. · Pubmed 27488494
  • Faculty of Kinesiology and Physical Education, University of Toronto, 55 Harbord Street, Toronto, ON, M5S2W6, Canada. · School of Kinesiology, University of British Columbia, 2146 Health Sciences Mall, Room 4606, Vancouver, BC, V6T 1Z3, Canada. · Mood Disorders Psychopharmacology Unit, Toronto Western Hospital, University Health Network, 399 Bathurst Street, MP 9-325, Toronto, ON, M5T 2S8, Canada. · Schizophrenia Program Centre for Addiction and Mental Health, 250 College Street, Toronto, ON, M5T 1R8, Canada. · School of Kinesiology, University of British Columbia, 2146 Health Sciences Mall, Room 4606, Vancouver, BC, V6T 1Z3, Canada. · Pubmed 27405745
  • Department of Psychiatry, Research Group in Behavioral Neuroscience of Bipolar Disorder (GP-TB), Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Department of Psychiatry, Clinic for Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany. · Vila Maria Outpatient Clinic, São Paulo, Brazil. · Department of Psychiatry, Irmandade da Santa Casa de Misericórdia de São Paulo (ISCMSP), São Paulo, Brazil. · Psychiatric Center Copenhagen, University of Copenhagen, Copenhagen, Denmark. · Bipolar Disorder Program and Laboratory of Molecular Psychiatry, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil. · Pubmed 27324989
  • Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil; Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. Electronic address: · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil; Department of Psychiatry, Clinic for Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany. · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil. · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil; Vila Maria Outpatient Clinic, São Paulo, Brazil. · Department of Psychiatry, Irmandade da Santa Casa de Misericórdia de São Paulo (ISCMSP), Brazil. · Medical University of Graz, Department of Psychiatry, Graz, Austria. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Pubmed 27281261
  • Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil; Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. Electronic address: · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil; Department of Psychiatry, Clinic for Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany. · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil. · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil; Vila Maria Outpatient Clinic in São Paulo, Brazil. · Department of Psychiatry, Irmandade da Santa Casa de Misericórdia de São Paulo (ISCMSP), Brazil. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Pubmed 26866976
  • Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada. · Cleveland Clinic, Cleveland, OH, USA. · Turn2Health Solutions, Willoughby, OH, USA. · Translational Psychiatry Research Group and Department of Clinical Medicine, Faculty of Medicine, Federal University of Ceara, Fortaleza, Brazil. · Department of Neuropsychiatry, University of South Carolina School of Medicine, USA. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada; Department of Pharmacology, University of Toronto, Toronto, ON, Canada. Electronic address: · Pubmed 26508286
2015
  • Mood Disorder Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada. · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Federal University of Sao Paulo, Sao Paulo, Brazil; Program of Recognition and Intervention in Individuals in AT-Risk Mental States (PRISMA), Department of Psychiatry, Universidade FeInterdisciplinary Laboratory of Clinical Neurosciences (LINC), Federal University of Sao Pauloderal de São Paulo, São Paulo, Brazil. · Mood Disorder Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Federal University of Sao Paulo, Sao Paulo, Brazil; Program of Recognition and Intervention in Individuals in AT-Risk Mental States (PRISMA), Department of Psychiatry, Universidade FeInterdisciplinary Laboratory of Clinical Neurosciences (LINC), Federal University of Sao Pauloderal de São Paulo, São Paulo, Brazil. · Mood Disorder Psychopharmacology Unit, University Health Network, Toronto, ON, Canada. · Mood Disorder Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada. Electronic address: · Pubmed 26363613
  • Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Department of Pharmacology, University of Toronto, Toronto, ON, Canada; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada. Electronic address: · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada. · Cleveland Clinic, Cleveland, OH, USA. · Medco Health Solutions, Inc, Fort Worth, TX, USA. · Translational Psychiatry Research Group and Department of Clinical Medicine, Faculty of Medicine, Federal University of Ceara, Fortaleza, Brazil. · Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada. · Pubmed 25451425
2014
  • Program for Recognition and Intervention in Individuals in At-Risk Mental States (PRISMA), Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil; Interdisciplinary Laboratory of Clinical Neuroscience (LINC), Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil. · Program for Recognition and Intervention in Individuals in At-Risk Mental States (PRISMA), Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil; Interdisciplinary Laboratory of Clinical Neuroscience (LINC), Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada. · Sunnybrook Research Institute, University of Toronto, Toronto, Ontario, Canada. · Interdisciplinary Laboratory of Clinical Neuroscience (LINC), Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil; Department of Morphology and Genetics, Federal University of São Paulo, São Paulo, Brazil. · Institute of Biomedical Research and Faculty of Biosciences, Pontifical Catholic University of Rio Grande do Sul, Porto Alegre, Brazil. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada; Sunnybrook Research Institute, University of Toronto, Toronto, Ontario, Canada. · Program for Recognition and Intervention in Individuals in At-Risk Mental States (PRISMA), Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil; Interdisciplinary Laboratory of Clinical Neuroscience (LINC), Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil. Electronic address: · Pubmed 24548785
2013
  • 1 Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada. · 3 Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada. · Pubmed 24237641
2016
  • Mood Disorders Psychopharmacology Unit, University Health Network, Department of Psychiatry and Pharmacology, University of Toronto, Toronto, Canada. · Department of Psychiatry, Western University, London and Windsor, ON, Canada. · IMPACT Strategic Research Centre, School of Medicine, Deakin University, Geelong, Vic., Australia. · Department of Psychiatry, The Florey Institute of Neuroscience and Mental Health, and Orygen, The National Centre of Excellence in Youth Mental Health, Centre for Youth Mental Health, University of Melbourne, Parkville, Vic., Australia. · Psychiatric Center Copenhagen, Faculty of Health and Medical Sciences and Department O, University of Copenhagen, Copenhagen, Denmark. · Discipline of Psychiatry, University of Adelaide, Adelaide, SA, Australia. · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Federal University of Sao Paulo, São Paulo, Brazil. · Program of Recognition and Intervention in Individuals in AT-Risk Mental States (PRISMA), Department of Psychiatry, Universidade Federal de São Paulo, São Paulo, Brazil. · Departments of Psychiatry, Pharmacology, and Psychological Clinical Science, Centre for Youth Bipolar Disorder, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada. · Pubmed 26990051
  • Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Federal University of São Paulo (UNIFESP), São Paulo, Brazil; Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. Electronic address: · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Federal University of São Paulo (UNIFESP), São Paulo, Brazil; Department of Psychiatry, Clinic for Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany. · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Federal University of São Paulo (UNIFESP), São Paulo, Brazil. · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Federal University of São Paulo (UNIFESP), São Paulo, Brazil; Vila Maria Outpatient Clinic in São Paulo, Brazil. · Department of Psychiatry, Irmandade da Santa Casa de Misericórdia de São Paulo (ISCMSP), Brazil. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Pubmed 26748249
2014
  • Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Department of Pharmacology, University of Toronto, Toronto, ON, Canada; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada. · Pubmed 24330342
University of Toronto
2019
  • Psychiatric Clinic, Department of Neuroscience and Mental Health, University of Milan, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy. · Psychiatric Clinic, Department of Neuroscience and Mental Health, University of Milan, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy. Electronic address: · Mood Disorders Psychopharmacology Unit, Department of Psychiatry and Pharmacology, University Health Network, University of Toronto, Toronto, Canada. · Pubmed 30795487
  • Department of Pharmacology, Escola Paulista de Medicina (EPM), Universidade Federal de São Paulo (UNIFESP), Rua 3 de maio 100, Ed. INFAR, 3rd floor, CEP 04044-020 São Paulo, Brazil. · Department of Psychiatry, Irmandade da Santa Casa de Misericórdia de São Paulo (ISCMSP), São Paulo, Brazil. · Mood Disorders Psychopharmacology Unit, Toronto Western Hospital, University Health Network, Toronto, ON, Canada. · Department of Psychiatry, Escola Paulista de Medicina (EPM), Universidade Federal de São Paulo (UNIFESP), Rua Pedro de Toledo, 669, 3rd floor, Vila Clementino, CEP 04039-032 São Paulo, Brazil. Electronic address: · Department of Pharmacology, Escola Paulista de Medicina (EPM), Universidade Federal de São Paulo (UNIFESP), Rua 3 de maio 100, Ed. INFAR, 3rd floor, CEP 04044-020 São Paulo, Brazil. Electronic address: · Pubmed 30321766
2018
  • Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Institute of Medical Science, University of Toronto, Toronto, ON M5S 1A8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Department of Psychiatry, University of Toronto, Toronto, ON M5T 1R8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Institute of Medical Science, University of Toronto, Toronto, ON M5S 1A8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Institute of Medical Science, University of Toronto, Toronto, ON M5S 1A8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Institute of Medical Science, University of Toronto, Toronto, ON M5S 1A8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Department of Psychiatry, Federal University of São Paulo, São Paulo 05403-903, Brazil. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Department of Psychiatry, University of Toronto, Toronto, ON M5T 1R8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Institute of Medical Science, University of Toronto, Toronto, ON M5S 1A8, Canada. · Department of Psychiatry, University of Toronto, Toronto, ON M5T 1R8, Canada. · Department of Pharmacology, University of Toronto, 399 Bathurst Street, Toronto, ON M5T 2S8, Canada. · Pubmed 29673146
  • Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada; University of Toronto, Toronto, Canada. Electronic address: · Department of Psychiatry and Behavioral Sciences, McGovern Medical School at the University of Texas Health Science Center at Houston, Houston, USA. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, USA. · Institute of Medical Biochemistry Leopoldo de Meis, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil; Centre for Neuroscience Studies, Department of Biomedical and Molecular Sciences, Queen's University, Kingston, Canada. · Center for Neuroscience in Women's Health, Stanford University, Palo Alto, USA. · Laboratory of Neuroendocrinology, The Rockefeller University, New York, USA. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada; Department of Psychiatry, Universidade Federal de São Paulo, São Paulo, Brazil; Research Group in Molecular and Behavioral Neuroscience of Bipolar Disorder, Department of Psychiatry, Universidade Federal de São Paulo, SP, Brazil. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada; University of Toronto, Toronto, Canada. · Pubmed 30391805
  • Medical University of Graz, Department of Psychiatry and Psychotherapeutic Medicine, Graz, Austria. · Medical University of Graz, Department of Psychiatry and Psychotherapeutic Medicine, Graz, Austria. Electronic address: · Research Unit on Lifestyle and Inflammation-associated Risk Biomarkers, Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University Graz, Graz, Austria. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Pubmed 29433074
  • Department of Affective Disorders, The Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou, China. · Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada. · Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada. · Department of Pharmacology, University of Toronto, Toronto, Ontario, Canada. · Department of Psychiatry and Behavioral Sciences, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX, USA. · Laboratory of Emotion and Cognition, The Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou, China. · Laboratory of Neuropsychology, University of Hong Kong, Hong Kong. · Pubmed 28944976
  • Mood Disorders Psychopharmacology Unit (MDPU), Toronto Western Hospital, University Health Network (UHN), Toronto, ON, Canada. · Grupo de Pesquisa em Neurociência Comportamental e Molecular do Transtorno Bipolar, Departamento de Psiquiatria, Universidade Federal de São Paulo (UNIFESP), São Paulo, SP, Brazil. · Brain and Cognition Discovery Foundation (BCDF), Toronto, ON, Canada. · Pubmed 30156658
2017
  • Department of Affective Disorders, the Affiliated Hospital of Guangzhou Medical University, (Guangzhou Huiai Hospital), Guangzhou Medical University, Guangzhou, China. · Department of Psychiatry, University of Toronto, Toronto, ON, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada. · Department of Psychiatry, Universidade Federal de Sao Paulo, Sao Paulo, Brazil. · Institute of Medical Science, University of Toronto, Toronto, ON, Canada. · Department of Psychiatry and Behavioral Sciences, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX, USA. · Laboratory of Emotion and Cognition, the Affiliated Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou Medical University, Guangzhou, China. · Laboratory of Neuropsychology, University of Hong Kong, Hong Kong, Hong Kong. · Pubmed 29023633
  • Department of Affective Disorders, The Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, China. · Department of Psychiatry, University of Toronto, Toronto, ON, Canada. · Institute of Medical Science, University of Toronto, Toronto, ON, Canada. · Department of Pharmacology, University of Toronto, Ontario, ON, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada. · Laboratory of Emotion and Cognition, the Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, China. · Laboratory of Neuropsychology, University of Hong Kong, Hong Kong. · Pubmed 28493605
  • Department of Psychiatry and Psychotherapy, Medical University of Graz, Graz, Austria. · Department of Psychiatry and Psychotherapy, Medical University of Graz, Graz, Austria. Electronic address: · Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Graz, Graz, Austria. · Division of Biological Chemistry, Biocenter, Medical University of Innsbruck, Innsbruck, Austria. · Institute of Laboratory Medicine, Medical Center of Munich University (LMU), Munich, Germany. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Pubmed 28482311
  • Reserach Group in Behavioral and Molecular Neuroscience of Bipolar Disorder, Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Department of Psychiatry, Clinic for Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany. · Vila Maria Outpatient Clinic, São Paulo, Brazil. · Department of Psychiatry, Irmandade da Santa Casa de Misericórdia de São Paulo (ISCMSP), São Paulo, Brazil. · Pubmed 28457001
  • Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada; Research Group in Molecular and Behavioral Neuroscience of Bipolar Disorder, Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil. Electronic address: · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Division of Endocrinology, Mount Sinai Hospital, University of Toronto, Toronto, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada; Paik Institute for Clinical Research, Inje University, Busan, Republic of Korea. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada; Department of Psychiatry, Samsung Seoul Hospital, Sungkyunkwan University, School of Medicine, Seoul, Republic of Korea. · Research Group in Molecular and Behavioral Neuroscience of Bipolar Disorder, Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil. · Medical University of Graz, Department of Psychiatry, Graz, Austria. · Research Division, Institute of Mental Health, Singapore. · Psychiatric Center Copenhagen, University of Copenhagen, Copenhagen, Denmark. · Department of Psychiatry, Stanford University, Palo Alto, CA, United States. · Department of Psychiatry, Dalhousie University, Halifax, Canada. · Pubmed 27721184
2016
  • Research Group in Behavioral Neuroscience of Bipolar Disorder (GP-TB), Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Department of Psychiatry, Clinic for Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany. · Vila Maria Outpatient Clinic, São Paulo, Brazil. · Department of Psychiatry, Irmandade da Santa Casa de Misericórdia de São Paulo (ISCMSP), São Paulo, Brazil. · Pubmed 27488494
  • Faculty of Kinesiology and Physical Education, University of Toronto, 55 Harbord Street, Toronto, ON, M5S2W6, Canada. · School of Kinesiology, University of British Columbia, 2146 Health Sciences Mall, Room 4606, Vancouver, BC, V6T 1Z3, Canada. · Mood Disorders Psychopharmacology Unit, Toronto Western Hospital, University Health Network, 399 Bathurst Street, MP 9-325, Toronto, ON, M5T 2S8, Canada. · Schizophrenia Program Centre for Addiction and Mental Health, 250 College Street, Toronto, ON, M5T 1R8, Canada. · School of Kinesiology, University of British Columbia, 2146 Health Sciences Mall, Room 4606, Vancouver, BC, V6T 1Z3, Canada. · Pubmed 27405745
  • Department of Psychiatry, Research Group in Behavioral Neuroscience of Bipolar Disorder (GP-TB), Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Department of Psychiatry, Clinic for Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany. · Vila Maria Outpatient Clinic, São Paulo, Brazil. · Department of Psychiatry, Irmandade da Santa Casa de Misericórdia de São Paulo (ISCMSP), São Paulo, Brazil. · Psychiatric Center Copenhagen, University of Copenhagen, Copenhagen, Denmark. · Bipolar Disorder Program and Laboratory of Molecular Psychiatry, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil. · Pubmed 27324989
  • Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil; Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. Electronic address: · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil; Department of Psychiatry, Clinic for Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany. · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil. · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil; Vila Maria Outpatient Clinic, São Paulo, Brazil. · Department of Psychiatry, Irmandade da Santa Casa de Misericórdia de São Paulo (ISCMSP), Brazil. · Medical University of Graz, Department of Psychiatry, Graz, Austria. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Pubmed 27281261
  • Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil; Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. Electronic address: · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil; Department of Psychiatry, Clinic for Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany. · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil. · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil; Vila Maria Outpatient Clinic in São Paulo, Brazil. · Department of Psychiatry, Irmandade da Santa Casa de Misericórdia de São Paulo (ISCMSP), Brazil. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Pubmed 26866976
2016
  • Mood Disorders Psychopharmacology Unit, University Health Network, Department of Psychiatry and Pharmacology, University of Toronto, Toronto, Canada. · Department of Psychiatry, Western University, London and Windsor, ON, Canada. · IMPACT Strategic Research Centre, School of Medicine, Deakin University, Geelong, Vic., Australia. · Department of Psychiatry, The Florey Institute of Neuroscience and Mental Health, and Orygen, The National Centre of Excellence in Youth Mental Health, Centre for Youth Mental Health, University of Melbourne, Parkville, Vic., Australia. · Psychiatric Center Copenhagen, Faculty of Health and Medical Sciences and Department O, University of Copenhagen, Copenhagen, Denmark. · Discipline of Psychiatry, University of Adelaide, Adelaide, SA, Australia. · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Federal University of Sao Paulo, São Paulo, Brazil. · Program of Recognition and Intervention in Individuals in AT-Risk Mental States (PRISMA), Department of Psychiatry, Universidade Federal de São Paulo, São Paulo, Brazil. · Departments of Psychiatry, Pharmacology, and Psychological Clinical Science, Centre for Youth Bipolar Disorder, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada. · Pubmed 26990051
  • Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Federal University of São Paulo (UNIFESP), São Paulo, Brazil; Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. Electronic address: · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Federal University of São Paulo (UNIFESP), São Paulo, Brazil; Department of Psychiatry, Clinic for Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany. · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Federal University of São Paulo (UNIFESP), São Paulo, Brazil. · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Federal University of São Paulo (UNIFESP), São Paulo, Brazil; Vila Maria Outpatient Clinic in São Paulo, Brazil. · Department of Psychiatry, Irmandade da Santa Casa de Misericórdia de São Paulo (ISCMSP), Brazil. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Pubmed 26748249
2014
  • Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Department of Pharmacology, University of Toronto, Toronto, ON, Canada; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada. · Pubmed 24330342
2013
  • Department of Human Biology, University of Toronto, Toronto, ON, Canada. · Pubmed 24194362
Guangzhou Medical University
2018
  • Department of Affective Disorders, The Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou, China. · Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada. · Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada. · Department of Pharmacology, University of Toronto, Toronto, Ontario, Canada. · Department of Psychiatry and Behavioral Sciences, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX, USA. · Laboratory of Emotion and Cognition, The Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou, China. · Laboratory of Neuropsychology, University of Hong Kong, Hong Kong. · Pubmed 28944976
2017
  • Department of Affective Disorders, the Affiliated Hospital of Guangzhou Medical University, (Guangzhou Huiai Hospital), Guangzhou Medical University, Guangzhou, China. · Department of Psychiatry, University of Toronto, Toronto, ON, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada. · Department of Psychiatry, Universidade Federal de Sao Paulo, Sao Paulo, Brazil. · Institute of Medical Science, University of Toronto, Toronto, ON, Canada. · Department of Psychiatry and Behavioral Sciences, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX, USA. · Laboratory of Emotion and Cognition, the Affiliated Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou Medical University, Guangzhou, China. · Laboratory of Neuropsychology, University of Hong Kong, Hong Kong, Hong Kong. · Pubmed 29023633
Universidade Federal de Sao Paulo
2017
  • Reserach Group in Behavioral and Molecular Neuroscience of Bipolar Disorder, Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Department of Psychiatry, Clinic for Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany. · Vila Maria Outpatient Clinic, São Paulo, Brazil. · Department of Psychiatry, Irmandade da Santa Casa de Misericórdia de São Paulo (ISCMSP), São Paulo, Brazil. · Pubmed 28457001
  • Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada; Research Group in Molecular and Behavioral Neuroscience of Bipolar Disorder, Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil. Electronic address: · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Division of Endocrinology, Mount Sinai Hospital, University of Toronto, Toronto, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada; Paik Institute for Clinical Research, Inje University, Busan, Republic of Korea. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada; Department of Psychiatry, Samsung Seoul Hospital, Sungkyunkwan University, School of Medicine, Seoul, Republic of Korea. · Research Group in Molecular and Behavioral Neuroscience of Bipolar Disorder, Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil. · Medical University of Graz, Department of Psychiatry, Graz, Austria. · Research Division, Institute of Mental Health, Singapore. · Psychiatric Center Copenhagen, University of Copenhagen, Copenhagen, Denmark. · Department of Psychiatry, Stanford University, Palo Alto, CA, United States. · Department of Psychiatry, Dalhousie University, Halifax, Canada. · Pubmed 27721184
2016
  • Research Group in Behavioral Neuroscience of Bipolar Disorder (GP-TB), Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Department of Psychiatry, Clinic for Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany. · Vila Maria Outpatient Clinic, São Paulo, Brazil. · Department of Psychiatry, Irmandade da Santa Casa de Misericórdia de São Paulo (ISCMSP), São Paulo, Brazil. · Pubmed 27488494
  • Department of Psychiatry, Research Group in Behavioral Neuroscience of Bipolar Disorder (GP-TB), Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Department of Psychiatry, Clinic for Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany. · Vila Maria Outpatient Clinic, São Paulo, Brazil. · Department of Psychiatry, Irmandade da Santa Casa de Misericórdia de São Paulo (ISCMSP), São Paulo, Brazil. · Psychiatric Center Copenhagen, University of Copenhagen, Copenhagen, Denmark. · Bipolar Disorder Program and Laboratory of Molecular Psychiatry, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil. · Pubmed 27324989
  • Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil; Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. Electronic address: · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil; Department of Psychiatry, Clinic for Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany. · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil. · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil; Vila Maria Outpatient Clinic, São Paulo, Brazil. · Department of Psychiatry, Irmandade da Santa Casa de Misericórdia de São Paulo (ISCMSP), Brazil. · Medical University of Graz, Department of Psychiatry, Graz, Austria. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Pubmed 27281261
  • Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil; Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. Electronic address: · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil; Department of Psychiatry, Clinic for Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany. · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil. · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil; Vila Maria Outpatient Clinic in São Paulo, Brazil. · Department of Psychiatry, Irmandade da Santa Casa de Misericórdia de São Paulo (ISCMSP), Brazil. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Pubmed 26866976
2015
  • Program for Recognition and Intervention in Individuals in At-Risk Mental States (PRISMA), Department of Psychiatry, Universidade Federal de São Paulo, São Paulo, SP, Brazil. · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, UNIFESP, São Paulo, SP, Brazil. · Developmental Cognitive Neuroscience Research Group (GNCD), Centre of Studies and Research in Traumatic Stress (NEPTE), Biomedical Research Institute, Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, RS, Brazil. · The Zucker Hillside Hospital, Psychiatry Research, North Shore - Long Island Jewish Health System, Glen Oaks, New York, NY, USA. · Pubmed 26692432
  • Mood Disorder Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada. · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Federal University of Sao Paulo, Sao Paulo, Brazil; Program of Recognition and Intervention in Individuals in AT-Risk Mental States (PRISMA), Department of Psychiatry, Universidade FeInterdisciplinary Laboratory of Clinical Neurosciences (LINC), Federal University of Sao Pauloderal de São Paulo, São Paulo, Brazil. · Mood Disorder Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Federal University of Sao Paulo, Sao Paulo, Brazil; Program of Recognition and Intervention in Individuals in AT-Risk Mental States (PRISMA), Department of Psychiatry, Universidade FeInterdisciplinary Laboratory of Clinical Neurosciences (LINC), Federal University of Sao Pauloderal de São Paulo, São Paulo, Brazil. · Mood Disorder Psychopharmacology Unit, University Health Network, Toronto, ON, Canada. · Mood Disorder Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada. Electronic address: · Pubmed 26363613
2014
  • Program for Recognition and Intervention in Individuals in At-Risk Mental States (PRISMA), Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil; Interdisciplinary Laboratory of Clinical Neuroscience (LINC), Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil. · Program for Recognition and Intervention in Individuals in At-Risk Mental States (PRISMA), Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil; Interdisciplinary Laboratory of Clinical Neuroscience (LINC), Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada. · Sunnybrook Research Institute, University of Toronto, Toronto, Ontario, Canada. · Interdisciplinary Laboratory of Clinical Neuroscience (LINC), Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil; Department of Morphology and Genetics, Federal University of São Paulo, São Paulo, Brazil. · Institute of Biomedical Research and Faculty of Biosciences, Pontifical Catholic University of Rio Grande do Sul, Porto Alegre, Brazil. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada; Sunnybrook Research Institute, University of Toronto, Toronto, Ontario, Canada. · Program for Recognition and Intervention in Individuals in At-Risk Mental States (PRISMA), Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil; Interdisciplinary Laboratory of Clinical Neuroscience (LINC), Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil. Electronic address: · Pubmed 24548785
2013
  • Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Universidade Federal de São Paulo, São Paulo, Brazil. · Pubmed 23266709
2016
  • Mood Disorders Psychopharmacology Unit, University Health Network, Department of Psychiatry and Pharmacology, University of Toronto, Toronto, Canada. · Department of Psychiatry, Western University, London and Windsor, ON, Canada. · IMPACT Strategic Research Centre, School of Medicine, Deakin University, Geelong, Vic., Australia. · Department of Psychiatry, The Florey Institute of Neuroscience and Mental Health, and Orygen, The National Centre of Excellence in Youth Mental Health, Centre for Youth Mental Health, University of Melbourne, Parkville, Vic., Australia. · Psychiatric Center Copenhagen, Faculty of Health and Medical Sciences and Department O, University of Copenhagen, Copenhagen, Denmark. · Discipline of Psychiatry, University of Adelaide, Adelaide, SA, Australia. · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Federal University of Sao Paulo, São Paulo, Brazil. · Program of Recognition and Intervention in Individuals in AT-Risk Mental States (PRISMA), Department of Psychiatry, Universidade Federal de São Paulo, São Paulo, Brazil. · Departments of Psychiatry, Pharmacology, and Psychological Clinical Science, Centre for Youth Bipolar Disorder, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada. · Pubmed 26990051
  • Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Federal University of São Paulo (UNIFESP), São Paulo, Brazil; Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. Electronic address: · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Federal University of São Paulo (UNIFESP), São Paulo, Brazil; Department of Psychiatry, Clinic for Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany. · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Federal University of São Paulo (UNIFESP), São Paulo, Brazil. · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Federal University of São Paulo (UNIFESP), São Paulo, Brazil; Vila Maria Outpatient Clinic in São Paulo, Brazil. · Department of Psychiatry, Irmandade da Santa Casa de Misericórdia de São Paulo (ISCMSP), Brazil. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Pubmed 26748249
2013
  • Program for Recognition and Intervention in Individuals in at Risk Mental States (PRISMA), Department of Psychiatry, Universidade Federal de São Paulo, São Paulo, Brazil. · Pubmed 23898851
  • Program for Recognition and Intervention in Individuals in At-Risk Mental States, Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil. · Pubmed 23489403
  • Department of Psychiatry, Universidade Federal de São Paulo, São Paulo, Brazil. · Pubmed 23484676
2012
  • Program for Recognition and Intervention in Individuals in at Risk Mental State, Department of Psychiatry, Universidade Federal de São Paulo, São Paulo, Brazil. · Pubmed 22613185
  • Program for Recognition and Intervention in Individuals in at Risk Mental States (PRISMA), Department of Psychiatry, Universidade Federal de São Paulo, São Paulo, Brazil. · Pubmed 22406334
  • Program for Recognition and Intervention in Individuals in at Risk Mental States (PRISMA), Department of Psychiatry, Universidade Federal de São Paulo, São Paulo, Brazil. · Pubmed 22365650
Unspecified
University of Sao Paulo
2015
  • Mood Disorder Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada. · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Federal University of Sao Paulo, Sao Paulo, Brazil; Program of Recognition and Intervention in Individuals in AT-Risk Mental States (PRISMA), Department of Psychiatry, Universidade FeInterdisciplinary Laboratory of Clinical Neurosciences (LINC), Federal University of Sao Pauloderal de São Paulo, São Paulo, Brazil. · Mood Disorder Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Federal University of Sao Paulo, Sao Paulo, Brazil; Program of Recognition and Intervention in Individuals in AT-Risk Mental States (PRISMA), Department of Psychiatry, Universidade FeInterdisciplinary Laboratory of Clinical Neurosciences (LINC), Federal University of Sao Pauloderal de São Paulo, São Paulo, Brazil. · Mood Disorder Psychopharmacology Unit, University Health Network, Toronto, ON, Canada. · Mood Disorder Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada. Electronic address: · Pubmed 26363613
2014
  • Program for Recognition and Intervention in Individuals in At-Risk Mental States (PRISMA), Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil; Interdisciplinary Laboratory of Clinical Neuroscience (LINC), Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil. · Program for Recognition and Intervention in Individuals in At-Risk Mental States (PRISMA), Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil; Interdisciplinary Laboratory of Clinical Neuroscience (LINC), Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada. · Sunnybrook Research Institute, University of Toronto, Toronto, Ontario, Canada. · Interdisciplinary Laboratory of Clinical Neuroscience (LINC), Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil; Department of Morphology and Genetics, Federal University of São Paulo, São Paulo, Brazil. · Institute of Biomedical Research and Faculty of Biosciences, Pontifical Catholic University of Rio Grande do Sul, Porto Alegre, Brazil. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada; Sunnybrook Research Institute, University of Toronto, Toronto, Ontario, Canada. · Program for Recognition and Intervention in Individuals in At-Risk Mental States (PRISMA), Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil; Interdisciplinary Laboratory of Clinical Neuroscience (LINC), Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil. Electronic address: · Pubmed 24548785
2016
  • Mood Disorders Psychopharmacology Unit, University Health Network, Department of Psychiatry and Pharmacology, University of Toronto, Toronto, Canada. · Department of Psychiatry, Western University, London and Windsor, ON, Canada. · IMPACT Strategic Research Centre, School of Medicine, Deakin University, Geelong, Vic., Australia. · Department of Psychiatry, The Florey Institute of Neuroscience and Mental Health, and Orygen, The National Centre of Excellence in Youth Mental Health, Centre for Youth Mental Health, University of Melbourne, Parkville, Vic., Australia. · Psychiatric Center Copenhagen, Faculty of Health and Medical Sciences and Department O, University of Copenhagen, Copenhagen, Denmark. · Discipline of Psychiatry, University of Adelaide, Adelaide, SA, Australia. · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Federal University of Sao Paulo, São Paulo, Brazil. · Program of Recognition and Intervention in Individuals in AT-Risk Mental States (PRISMA), Department of Psychiatry, Universidade Federal de São Paulo, São Paulo, Brazil. · Departments of Psychiatry, Pharmacology, and Psychological Clinical Science, Centre for Youth Bipolar Disorder, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada. · Pubmed 26990051
  • Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Federal University of São Paulo (UNIFESP), São Paulo, Brazil; Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. Electronic address: · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Federal University of São Paulo (UNIFESP), São Paulo, Brazil; Department of Psychiatry, Clinic for Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany. · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Federal University of São Paulo (UNIFESP), São Paulo, Brazil. · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Federal University of São Paulo (UNIFESP), São Paulo, Brazil; Vila Maria Outpatient Clinic in São Paulo, Brazil. · Department of Psychiatry, Irmandade da Santa Casa de Misericórdia de São Paulo (ISCMSP), Brazil. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Pubmed 26748249
2013
  • Program for Recognition and Intervention in Individuals in At-Risk Mental States, Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil. · Pubmed 23489403
Yearly article counts 36793263000
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.